作为中国最大的制药研发数字解决方案供应商, 浙江太梅医疗技术公司开始以HKSE为首进行交易。 Zhejiang Taimei Medical Technology begins trading on the HKSE as China's largest digital solution provider for pharma R&D.

浙江太明医疗科技有限公司 开始在香港证券交易所进行交易 代号是"2576" Zhejiang Taimei Medical Technology Co., Ltd. has begun trading on the Hong Kong Stock Exchange under the code "2576." 截至2023年,中国是中国最大的药品和医疗设备研发数字解决方案提供国,市场份额占5.9%。 As of 2023, it is China's largest digital solution provider for pharmaceutical and medical device R&D, holding a 5.9% market share. 该公司向1 400多名客户提供了40多种软件产品和服务,其中包括许多全球顶级制药公司。 The company offers over 40 software products and services to more than 1,400 clients, including many top global pharmaceutical firms. Taimei计划增加其供货,扩大客户基础。 Taimei plans to enhance its offerings and expand its customer base.